Aaron N. Nguyen

Aaron N. Nguyen has extensive work experience in the field of translational research and medicine. Aaron N. is currently serving as the Senior Director of Translational Research at Senti Biosciences since December 2022. Prior to this, they held the position of Head of Translational Medicine at Adagene from October 2020 to November 2022.

Before joining Adagene, Aaron worked as the Associate Director of Translational Sciences at Sparcbio from June 2019 to October 2020. Aaron N. also served as a Principal Scientist at Pharmacyclics, an AbbVie Company, from June 2018 to April 2019.

Aaron's earlier work experience includes their tenure at Celgene, where they held various positions such as Principal Scientist, Senior Scientist, and Scientist II from September 2007 to June 2018. Prior to Celgene, they worked as a Scientist II at Odyssey Thera from 2006 to 2007 and at Scios, a Johnson & Johnson company, from 2002 to 2006, where they started as a Postdoc and progressed to the roles of Scientist I and Scientist II.

Overall, Aaron N. Nguyen has accumulated extensive experience in translational research and medicine throughout their career, with notable roles in both industry and academic settings.

Aaron N. Nguyen earned a PhD in Biochemistry and Molecular Biology from the University of California, Davis. Aaron N. attended the university from 1997 to 2002.